Biotech Candidates
Update
Biotech Candidates
Biotech Candidates — April 10, 2026
Overview
Biotech mixed. Large-cap pharma holding: AMGN $352.56 RSI 48, weak-down but golden cross intact, +11.0% vs SMA200. GILD $140.70 RSI 50, weak-down golden cross, +13.7% vs SMA200. REGN $748.15 RSI 46, weak-down golden cross. ABBV pulled back to RSI 44, -4.7% vs SMA50. Gene editing names weakened: CRSP RSI 33 in strong-down. VRTX crashed further. LLY not in current biotech summary but was trending weak-down. The pharma defense thesis is intact but gene editing/speculative biotech is struggling.
Candidates
| Ticker | Price | RSI | Trend | 7D | 30D | Signal | Take |
|---|---|---|---|---|---|---|---|
| GILD | $140.70 | 50.0 | weak-down | +1.2% | -4.8% | GC | Golden cross. +13.7% vs SMA200. Stable pharma. Above SMA20 (+0.6%). |
| AMGN | $352.56 | 48.0 | weak-down | +2.4% | -6.1% | GC | Golden cross. +11.0% vs SMA200. RSI 48 neutral. +0.2% vs SMA20. |
| REGN | $748.15 | 45.6 | weak-down | +0.3% | -3.1% | GC | Regeneron stable. -0.7% vs SMA20. +12.0% vs SMA200. Golden cross. |
| ABBV | $210.23 | 44.1 | down | +2.1% | -7.4% | GC | Pulled back from highs. -0.4% vs SMA20. -2.2% vs SMA200. Golden cross. |
| CRSP | $37.38 | 33.3 | strong-down | -3.0% | -25.8% | DC | Gene editing broken. -10.0% vs SMA20. -43.1% vs SMA200. Death cross. |
| ISRG | $450.02 | 35.0 | strong-down | -0.4% | -7.4% | DC | Surgical robotics. -3.4% vs SMA20. -10.9% vs SMA200. Death cross. |
Action Items
- GILD: RSI 50 + golden cross + +13.7% vs SMA200. Best risk/reward in biotech. Defensive pharma play. Hold/add.
- AMGN: RSI 48, golden cross, +11% vs SMA200. Quality large-cap pharma. Hold.
- REGN: Stable at RSI 46. Golden cross intact. No urgency but no reason to sell.
- ABBV: Pulled back -7.4% 30D. Golden cross + -0.4% vs SMA20 means near support. Watch RSI 40 for entry.
- CRSP: -25.8% 30D crash. Death cross + -43.1% vs SMA200. Gene editing is broken. Avoid.
- ISRG: RSI 35 approaching oversold. Death cross. -10.9% vs SMA200. Quality name but broken chart. Watch.
Key Changes vs 04/03
Related
10 eventsNo direct external sources are attached to this read.